AsthmaSense Cloud Launches With New Features To Better Monitor Asthma
iSonea Ltd. Unveils Newest Smartphone Application
PR Newswire
SEVERNA PARK, Md., April 11, 2013
SEVERNA PARK, Md. , April 11, 2013 /PRNewswire/ -- Medical technology company, iSonea Ltd. (ASX: ISN; OTCQX: ISOAY), launched Thursday the newest smartphone asthma management application, AsthmaSense ™ Cloud , to help asthmatics adhere to physician-prescribed treatment plans.
(Photo: http://photos.prnewswire.com/prnh/20130411/CL93383 )
The AsthmaSense Cloud application, available on iPhone and Android platforms, has enhanced features to track and manage chronic asthma including:
- Safe storage of a user's asthma profile and event history in a password-protected, HIPAA-compliant, cloud-based data warehouse;
- Protected access and easy data recovery if one's phone is replaced, lost, stolen or damaged;
- Ability to view and edit the application data on a computer;
- Tracking system to identify potential risk patterns and trends in asthma symptoms, medication use and testing results;
- Interactive medication and testing reminders as well as medication usage records;
- One-touch dialing of contact numbers, including auto-selected emergency number based on GPS location; and
- The ability to maintain multiple user profiles with a single application; a benefit to families with more than one person suffering from asthma.
"Growing asthma trends represent a serious challenge in the United States and globally," said Michael J. Thomas , chief executive officer for iSonea. "The need for better, consumer-friendly asthma management tools is critical to improve the patient's well being while reducing costs.
"By improving awareness of symptoms, asthma episodes, medication usage and potential risks, AsthmaSense Cloud can help asthmatics adhere to a physician-prescribed treatment plan."
According to the Centers for Disease Control and Prevention, an estimated 25 million adults and children in the United States have asthma. It is estimated that asthma affects 300 million people globally, and an additional 100 million people will suffer from asthma by 2025 1 . Increased emergency room visits, hospitalizations, medical costs and deaths reinforce the need for better monitoring.
The AsthmaSense smartphone application provides patients and caregivers with an easy-to-use monitoring tool that sends alerts and reminders to help manage the condition in accordance with a physician-prescribed treatment plan. The addition of a convenient cloud portal increases the flexibility of storing, sharing and editing data.
AsthmaSense Cloud is available on iPhone and Android devices and may be downloaded for free from Apple iTunes , Google Play and Amazon application stores.
For more information, please visit www.soundasthma.com or www.iSoneaMed.com .
About iSonea Limited:
iSonea Limited (ASX:ISN; OTCQX:ISOAY) is an emerging medical technology company developing innovative, non-invasive devices and mobile health apps to improve the management of chronic, costly respiratory disorders such as asthma and COPD. By leveraging iSonea's proprietary Acoustic Respiratory Monitoring™ (ARM) technology with its AsthmaSense™ mobile applications, iSonea is creating a better monitoring system—enabling anyone, anywhere, at any time to monitor breathing distress symptoms, in order to take action. iSonea's ARM devices have been cleared for use by the U.S. Food and Drug Administration, the Australian TGA and the European Union. For more information, please visit www.soundasthma.com or www.iSoneaMed.com .
Forward Looking Statements
Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on iSonea's current expectations, estimates and projections about the industry in which iSonea operates, and its beliefs and assumptions. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance" and similar expressions are intended to identify forward-looking statements and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those risks or uncertainties inherent in the process of developing technology and in the endeavor of building a business around such products and services. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors, some of which are beyond the control of iSonea, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. iSonea cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of iSonea only as of the date of this release. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. iSonea will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.
[1] World Health Organization. "Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach." (2007): page 16. Accessed Feb. 1, 2013 http://www.who.int/gard/publications/GARD%20Book%202007.pdf .
SOURCE iSonea Limited
test123 kjk
